| Symbol |
Name |
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ADAMTS15
|
ADAM metallopeptidase with thrombospondin type 1 motif, 15
|
|
ADAMTS7
|
ADAM metallopeptidase with thrombospondin type 1 motif, 7
|
|
ADH5
|
alcohol dehydrogenase 5 (class III), chi polypeptide
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AKR1C2
|
aldo-keto reductase family 1, member C2
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
APC
|
adenomatous polyposis coli
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARID2
|
AT rich interactive domain 2 (ARID, RFX-like)
|
|
ARMC5
|
armadillo repeat containing 5
|
|
ATG12
|
autophagy related 12
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
B3GALNT1
|
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BAX
|
BCL2-associated X protein
|
|
BLVRA
|
biliverdin reductase A
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BTG2
|
BTG family, member 2
|
|
C1GALT1C1
|
C1GALT1-specific chaperone 1
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CARM1
|
coactivator-associated arginine methyltransferase 1
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCNB1
|
cyclin B1
|
|
CCNT1
|
cyclin T1
|
|
CDC42
|
cell division cycle 42
|
|
CDC73
|
cell division cycle 73
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK14
|
cyclin-dependent kinase 14
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CLPTM1
|
cleft lip and palate associated transmembrane protein 1
|
|
COL4A3BP
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein
|
|
CREBBP
|
CREB binding protein
|
|
CRYAA
|
crystallin, alpha A
|
|
CSNK1G2
|
casein kinase 1, gamma 2
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CUX1
|
cut-like homeobox 1
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
DAXX
|
death-domain associated protein
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DMP1
|
dentin matrix acidic phosphoprotein 1
|
|
DUOX1
|
dual oxidase 1
|
|
DUOX2
|
dual oxidase 2
|
|
EED
|
embryonic ectoderm development
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
|
ESCO2
|
establishment of sister chromatid cohesion N-acetyltransferase 2
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FBXO10
|
F-box protein 10
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOXF1
|
forkhead box F1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GALNT12
|
polypeptide N-acetylgalactosaminyltransferase 12
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA6
|
GATA binding protein 6
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDI1
|
GDP dissociation inhibitor 1
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GNAS
|
GNAS complex locus
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL32
|
interleukin 32
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KDM5C
|
lysine (K)-specific demethylase 5C
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KISS1R
|
KISS1 receptor
|
|
LACRT
|
lacritin
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEMD3
|
LEM domain containing 3
|
|
LHB
|
luteinizing hormone beta polypeptide
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LMAN1
|
lectin, mannose-binding, 1
|
|
LOX
|
lysyl oxidase
|
|
LZTS2
|
leucine zipper, putative tumor suppressor 2
|
|
MAP1LC3B
|
microtubule-associated protein 1 light chain 3 beta
|
|
MAP3K3
|
mitogen-activated protein kinase kinase kinase 3
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MCFD2
|
multiple coagulation factor deficiency 2
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPO
|
myeloperoxidase
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NACC1
|
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NRP1
|
neuropilin 1
|
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
|
OTUD4
|
OTU deubiquitinase 4
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PBRM1
|
polybromo 1
|
|
PDE8B
|
phosphodiesterase 8B
|
|
PDK3
|
pyruvate dehydrogenase kinase, isozyme 3
|
|
PGR
|
progesterone receptor
|
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPM1A
|
protein phosphatase, Mg2+/Mn2+ dependent, 1A
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PRDX6
|
peroxiredoxin 6
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGES3
|
prostaglandin E synthase 3 (cytosolic)
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RB1
|
retinoblastoma 1
|
|
RET
|
ret proto-oncogene
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RNF216
|
ring finger protein 216
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
SEMA3B
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SETD2
|
SET domain containing 2
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SIAH1
|
siah E3 ubiquitin protein ligase 1
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC30A2
|
solute carrier family 30 (zinc transporter), member 2
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SNRPN
|
small nuclear ribonucleoprotein polypeptide N
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2
|
|
STAG2
|
stromal antigen 2
|
|
STK11
|
serine/threonine kinase 11
|
|
SUFU
|
suppressor of fused homolog (Drosophila)
|
|
SUV39H1
|
suppressor of variegation 3-9 homolog 1 (Drosophila)
|
|
SYNJ2
|
synaptojanin 2
|
|
TAGLN2
|
transgelin 2
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGIF1
|
TGFB-induced factor homeobox 1
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPO
|
thyroid peroxidase
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSPY1
|
testis specific protein, Y-linked 1
|
|
TSPYL2
|
TSPY-like 2
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WWP1
|
WW domain containing E3 ubiquitin protein ligase 1
|
|
YBX1
|
Y box binding protein 1
|
|
ZMPSTE24
|
zinc metallopeptidase STE24
|
